The Trump administration is releasing new guidelines that would bolster Medicaid’s oversight of autism therapy, focusing on a rapidly growing business that is drawing scrutiny from federal investigators.
"CMS has released new guidance aimed at strengthening oversight of autism therapy programs, with recommendations related to provider supervision, documentation, telehealth practices, licensing, and fraud prevention. While not every recommendation applies directly to every ABA agency, it highlights the growing regulatory focus on accountability and operational quality."
WSJ
The recommendations
The recommendations, from the Centers for Medicare and Medicaid Services, are aimed at state Medicaid agencies, but they will likely draw attention from private insurers and employers as well. They focus on applied behavior analysis, or ABA, a type of therapy that is supposed to help autistic people manage behavior and develop daily living and social skills.
Read the official article:
